Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$3.25M Sell
21,288
-3,061
-13% -$449K 0.02% 583
2019
Q3
$3.52M Buy
24,349
+2,202
+10% +$329K 0.03% 534
2019
Q2
$3.3M Sell
22,147
-149
-0.7% -$19.9K 0.03% 558
2019
Q1
$2.85M Buy
22,296
+1,253
+6% +$147K 0.02% 578
2018
Q4
$2.25M Sell
21,043
-910
-4% -$102K 0.02% 592
2018
Q3
$2.51M Buy
21,953
+13,703
+166% +$1.55M 0.03% 563
2018
Q2
$867K Buy
8,250
+693
+9% +$69.7K 0.01% 945
2018
Q1
$706K Sell
7,557
-770
-9% -$70K 0.01% 1082
2017
Q4
$729K Buy
8,327
+1,953
+31% +$174K 0.01% 1092
2017
Q3
$565K Sell
6,374
-203
-3% -$17.2K 0.01% 1127
2017
Q2
$537K Buy
6,577
+91
+1% +$6.92K 0.01% 1108
2017
Q1
$451K Buy
6,486
+196
+3% +$13.6K 0.01% 1142
2016
Q4
$423K Buy
6,290
+1,251
+25% +$84.8K 0.01% 1102
2016
Q3
$368K Buy
5,039
+300
+6% +$21.2K 0.01% 1149
2016
Q2
$325K Buy
+4,739
New +$332K 0.01% 1160

Other funds holding STE

Advisor Group's STE Position: Q4 2019 in Review

Advisor Group reduced its Steris (STE) stake by 13% in Q4 2019, selling an estimated $449K and leaving 21,288 shares worth $3.25M. The position accounts for 0.02% of the portfolio, ranked #583.

Advisor Group first reported a position in STE in Q2 2016 and has held it in 15 quarters since. The position peaked at $3.52M in Q3 2019. 518 funds tracked by Wall St. Rank hold STE as of Q4 2019.

  • Advisor Group held 21,288 shares of Steris worth $3.25M as of Q4 2019.
  • Advisor Group sold 3,061 Steris shares in Q4 2019, an estimated $449K.
  • Steris made up 0.02% of Advisor Group's portfolio in Q4 2019, its #583 holding.
  • Advisor Group first reported a position in Steris in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Steris position peaked at $3.52M in Q3 2019.
  • 518 funds tracked by Wall St. Rank held Steris as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.